Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | IMM47 |
| Synonyms | |
| Therapy Description |
IMM47 is a monoclonal antibody that targets CD24, which may result in an increased antitumor immune response and tumor growth inhibition (Cancer Res (2023) 83 (7_Supplement): 6340). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| IMM47 | IMM 47|IMM-47 | CD24 Antibody 3 | IMM47 is a monoclonal antibody that targets CD24, which may result in an increased antitumor immune response and tumor growth inhibition (Cancer Res (2023) 83 (7_Supplement): 6340). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05985083 | Phase I | IMM47 | A Study Of IMM47 In Subjects With Advanced Solid Tumors | Unknown status | AUS | 0 |